Secondary structure-induced aggregation by hydrogen peroxide: a stimuli-triggered open/close implementation by recombination.
Guiyang ZhangQiaobo LiaoYanfeng LiuLi WangHuilin GouCan KeXin HuangKai XiXudong JiaPublished in: Nanoscale (2018)
The fabrication of reactive aggregation nanomaterials through assemblies in a facile and cost-effective manner is much desired but remains to be well explored. Here we show that exquisite and ultra-long (>2 μm) hybrid polymer nanorods (NRs) can be formed by a simple self-assembly of a phenylboronic acid modified genistein crosslinker (Ge-di(HMPBA-pin)) and d-α-tocopheryl polyethylene glycol 1000 (TPGS). The obtained NRs exhibit quantitative and sensitive colorimetric detection of H2O2 with a remarkable detection limit for different stromal materials. More significantly, the presence of H2O2 triggers a distinct morphological transformation of the polymer NR assembly into the secondary structure of micelles via the oxidative deboronation of boronate moieties in HMPBA-pin-SA. It spontaneously induces the aggregation of metal nanoparticles (Au NPs), metal nanorods (Au NRs), quantum dots (MoS2 QDs), metal ions (Cu2+), protein (ferritin) and tetraphenylethene (TPE) molecules, giving rise to a dramatic stimuli-triggered open/close switchable complexation and apparent colorimetric transitions in vitro. This study, for the first time, showcases the fascinating advantages of such unprecedented secondary structure-induced aggregation and uncovers the immense potential to design a plethora of other sensing systems by virtue of the alternate trigger-specific, sacrifice-aggregated building moieties.
Keyphrases
- hydrogen peroxide
- quantum dots
- sensitive detection
- reduced graphene oxide
- gold nanoparticles
- loop mediated isothermal amplification
- nitric oxide
- high glucose
- label free
- diabetic rats
- primary care
- minimally invasive
- high resolution
- aqueous solution
- healthcare
- bone marrow
- drug delivery
- drug induced
- computed tomography
- real time pcr
- dna damage
- cystic fibrosis
- amino acid
- escherichia coli
- magnetic resonance imaging
- quality improvement
- magnetic resonance
- mass spectrometry
- living cells
- staphylococcus aureus
- cancer therapy
- single molecule
- drug release